Regina Rabinovich
- Panel: Innovation and Strategies Against Malaria
Past Core Course:
- Cross-border Malaria: Key Challenges and Opportunities
- Panel: Achieving the R&D Agenda of the malERA Refresh through Partnership, Governance, and Alliances
- Communication, Dynamization of Science, and Social Media for Malaria Eradication
- The Global Architecture for Malaria Eradication
- The Role of Global Health Architecture in Elimination Efforts
- Global Health Architecture for Malaria Control and Eradication
- Priorities for Malaria Eradication R&D
- Introduction and Scaling of Innovation: Teaching Case Studies
- “Changing the Chip”
- Engaging Industry in Innovation for Elimination
- The Challenge of Malaria Eradication
Managing the End of Malaria:
- Making Innovation Work III: Making Innovation Work
Malaria: Breaking the Cycle:
- Managing Innovation in the Malaria Value and Supply Chain
- Scale-up to Elimination in Zambia
- Country Application: Lessons Learned and Implications of Scale-up to Elimination in Zambia
Dr Regina Rabinovich is a global health leader with over 25 years’ experience in the research, public health, and philanthropic sectors, with a focus on strategy, analytics, global health product development, and the introduction and scale-up of tools and strategies resulting in an impact on endemic populations. She is past president of the American Society of Tropical Medicine & Hygiene. Since 2012, she has served as the ExxonMobil Malaria Scholar in Residence at Harvard University and Chair of the Malaria Eradication Scientific Alliance (MESA), hosted at the Barcelona Institute for Global Health. As MESA Chair, she led the consultative process to ‘refresh’ the Malaria Eradication Research Agenda Refresh (malERA Refresh).
Prior to her role at Harvard University, Dr Rabinovich was the director of the Infectious Diseases Unit at the Bill & Melinda Gates Foundation where she oversaw the development and implementation of strategies for the prevention, treatment, and control of diseases of particular relevance to global health, including malaria, pneumonia, diarrhea, and neglected infectious diseases. During her tenure at the National Institute of Allergy and Infectious Diseases (NIAID), she helped develop and evaluate vaccines. In addition to participating in the Children’s Vaccine Initiative and liaising on issues related to vaccine safety and vaccine research, she managed the evaluation of candidate vaccines through a network of United States clinical research units. During her time as director of the PATH Malaria Vaccine Initiative, she advanced efforts to develop promising malaria vaccine candidates.
Dr Rabinovich serves on the boards of the NIAID Council, National Institutes of Health’s Council of Councils, PATH Vaccine Solutions, Aeras, and Harvard University’s Defeating Malaria: From the Genes to the Globe Initiative. She earned a Medical degree from Southern Illinois University and a master’s degree in Public Health from the University of North Carolina.